Related Experiment Video
Updated: Feb 17, 2026
14:58
Quantifying X-Ray Fluorescence Data Using MAPS
Published on: February 17, 2018
11.3K
The RA-MAP Consortium: a working model for academia-industry collaboration
Andrew P Cope1, Michael R Barnes2, Alexandra Belson3
1Centre for Inflammation Biology and Cancer Immunology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, Great Maze Pond, London, SE1 1UL, UK.
Nature Reviews. Rheumatology
|December 8, 2017
Summary
Large research consortia, like the RA-MAP group, face collaboration challenges. This perspective offers solutions for multi-partner research networks in genomic medicine.
Area of Science:
- Biomedical research
- Genomic medicine
- Rheumatoid arthritis
Background:
- Growing success of large, multi-partner research networks in biomedicine.
- Increased funding for genomic medicine and big data projects globally.
- Need for effective collaboration models in academic and industry research.
Observation:
- The RA-MAP consortium, comprising over 140 individuals from 21 organizations, aims to advance genomic medicine in rheumatoid arthritis.
- This perspective article details the experiences and challenges faced by the RA-MAP consortium.
- Focus on multi-partner collaboration within the UK context.
Findings:
- Identifies specific challenges encountered in large-scale, multi-partner research collaborations.
- Provides a range of practical solutions and strategies for overcoming these collaborative hurdles.
- Highlights the importance of addressing these challenges for successful genomic medicine implementation.
Implications:
- Offers valuable insights for other large research consortia globally.
- Aims to facilitate the realization of genomic medicine's potential through improved collaboration.
- Contributes to the advancement of rheumatoid arthritis research and treatment through big data insights.
